Executive Director, US Portfolio Analytics

Executive Director, US Portfolio Analytics

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

Reporting directly to the Vice President, US Analytics & Insights, the Executive Director, US Portfolio Analytics will lead the portfolio-wide analytics capabilities that enable data-driven commercial decision-making across Revolution Medicines' US business. This leader will be accountable for Field Analytics, Market Access Analytics, Data Strategy & Governance, Omnichannel Analytics, and Dashboards, ensuring scalable, integrated capabilities that support launch readiness, commercialization, and performance management across the portfolio.

This role will serve as a strategic thought partner to US Commercial leadership and franchise Analytics & Insights leaders, translating business priorities into an integrated analytics roadmap and establishing consistent standards, methodologies, data definitions, and decision support across brands and functions. The Executive Director will operate as a player/coach—personally engaging in high-priority analyses and capability design while building, leading, and developing a high-performing team.

Candidates should bring deep biopharma commercial analytics expertise, strong business and technical acumen, and a track record of building scalable analytics capabilities in an agile, fast-growing organization. This position is based out of our headquarters in Redwood City, CA.

Specifically, you will be responsible for:

• Portfolio analytics leadership.
• Field Analytics.
• Market Access Analytics.
• Data Strategy and Governance.
• Omnichannel Analytics.
• Reporting & business intelligence.
• Advanced analytics & innovation.
• Launch and lifecycle support.
• Cross-functional partnership.
• Vendor and resource management.
• People leadership.

Required Skills, Experience and

Education:

• Bachelor's degree in quantitative, scientific, engineering, or business discipline(s).
• 12+ years of relevant experience in biotechnology, pharmaceutical, life sciences, or consulting environments, with substantial experience in commercial analytics and progressive leadership responsibility consistent with Executive Director-level expectations.
• Demonstrated success building, leading, and developing high-performing analytics teams and scaling capabilities in a complex, fast-paced commercial organization.
• Broad commercial analytics expertise spanning field analytics, market access analytics, omnichannel analytics, reporting/business intelligence, and data strategy/governance, with deep hands-on expertise in several of these domains and the ability to lead across all of them.
• Deep knowledge of pharmaceutical commercial data, including claims and prescription data, HCP and account data, CRM and field activity, payer and formulary/access data, specialty pharmacy and patient-services data, and digital engagement data.
• Experience defining KPI frameworks, executive dashboards, and performance-management reporting that translate complex data into clear business insights and actions.
• Expe…